基于人工智能的工具在[18F]FDG PET/CT中评估多发性骨髓瘤骨髓受累的应用
研究纳入35例初治多发性骨髓瘤患者的全身[18F]FDG PET/CT,验证一种三维深度学习工具自动评估骨髓代谢强度。该工具在全部患者中可行,采用六种SUV阈值得到的MTV与TLG均与视觉分析分组及临床相关参数相关,作者认为该方法有助优化和标准化PET/CT判读。
要点
- 深度学习工具在35例初治多发性骨髓瘤患者的全身[18F]FDG PET/CT中均完成骨髓分割与MTV、TLG计算。
- 六种SUV阈值下MTV、TLG均与视觉分析三组呈显著正相关(p<0.05),三组间MTV、TLG均有显著差异。
- 采用Approach 1、2、4、5时,骨髓浆细胞浸润与β2-微球蛋白水平同MTV、TLG呈显著中度正相关。
核心结论
- 作者认为,本文方法对多发性骨髓瘤骨髓代谢活动的自动化全身容积PET/CT评估可行,且与疾病临床相关参数相关。
- 作者认为该方法有望成为优化和标准化多发性骨髓瘤PET/CT判读的可靠工具。
- 基于目前有希望的结果,该深度学习方法将在未来更大样本的前瞻性研究中进一步评估。
研究设计与样本
- 研究分析35例连续、既往未治疗的多发性骨髓瘤患者的全身[18F]FDG PET/CT,患者均来自一项开放标签、多中心、随机、活性对照的3期试验(GMMG-HD7)。
- 视觉(定性)分析依据有无及数量局灶性[18F]FDG高摄取病灶和骨髓弥漫性[18F]FDG摄取程度,将PET/CT分为三组。
- 自动化方法先基于CT分割骨骼并转移至SUV PET图像,再应用不同SUV阈值,并用后处理细化所得区域。
- 共应用六种SUV阈值(Approach 1–6)定义骨骼病理性示踪剂摄取,并据此计算全身代谢肿瘤体积(MTV)和病灶糖酵解总量(TLG)。
- 将自动化PET数值与视觉PET/CT分析结果及组织病理学、细胞遗传学和临床数据进行相关性分析。
主要发现
- 应用深度学习工具后,全部患者均可行骨髓分割及MTV、TLG计算。
- 视觉分析三组与采用全部六种[18F]FDG摄取阈值后的MTV、TLG值之间均呈显著正相关(p<0.05)。
- 在所有应用的病理性示踪剂摄取阈值下,三组患者间MTV、TLG值均存在显著差异。
- 采用Approach 1、2、4、5时,骨髓浆细胞浸润及血浆β2-微球蛋白水平与自动化定量PET/CT参数MTV、TLG呈显著中度正相关。
关键数值与推荐
- Approach 1:肝脏SUVmedian×1.1(中轴骨),臀肌SUVmedian×4(四肢)。
- Approach 2:肝脏SUVmedian×1.5(中轴骨),臀肌SUVmedian×4(四肢)。
- Approach 3:肝脏SUVmedian×2(中轴骨),臀肌SUVmedian×4(四肢)。
- Approach 4:≥2.5;Approach 5:≥2.5(中轴骨)、≥2.0(四肢);Approach 6:肝脏SUVmax。
局限性
- 作者在结论中指出,基于目前有希望的结果,该深度学习方法将在未来更大样本的前瞻性研究中进一步评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: [18F]FDG PET/CT is an imaging modality of high performance in multiple myeloma (MM). Nevertheless, the inter-observer reproducibility in PET/CT scan interpretation may be hampered by the different patterns of bone marrow (BM) infiltration in the disease. Although many approaches have been recently developed to address the issue of standardization, none can yet be considered a standard method in the interpretation of PET/CT. We herein aim to validate a novel three-dimensional deep learning-based tool on PET/CT images for automated assessment of the intensity of BM metabolism in MM patients. MATERIALS AND METHODS: Whole-body [18F]FDG PET/CT scans of 35 consecutive, previously untreated MM patients were studied. All patients were investigated in the context of an open-label, multicenter, randomized, active-controlled, phase 3 trial (GMMG-HD7). Qualitative (visual) analysis classified the PET/CT scans into three groups based on the presence and number of focal [18F]FDG-avid lesions as well as the degree of diffuse [18F]FDG uptake in the BM. The proposed automated method for BM metabolism assessment is based on an initial CT-based segmentation of the skeleton, its transfer to the SUV PET images, the subsequent application of different SUV thresholds, and refinement of the resulting regions using postprocessing. In the present analysis, six different SUV thresholds (Approaches 1-6) were applied for the definition of pathological tracer uptake in the skeleton [Approach 1: liver SUVmedian × 1.1 (axial skeleton), gluteal muscles SUVmedian × 4 (extremities). Approach 2: liver SUVmedian × 1.5 (axial skeleton), gluteal muscles SUVmedian × 4 (extremities). Approach 3: liver SUVmedian × 2 (axial skeleton), gluteal muscles SUVmedian × 4 (extremities). Approach 4: ≥ 2.5. Approach 5: ≥ 2.5 (axial skeleton), ≥ 2.0 (extremities). Approach 6: SUVmax liver]. Using the resulting masks, subsequent calculations of the whole-body metabolic tumor volume (MTV) and total lesion glycolysis (TLG) in each patient were performed. A correlation analysis was performed between the automated PET values and the results of the visual PET/CT analysis as well as the histopathological, cytogenetical, and clinical data of the patients. RESULTS: BM segmentation and calculation of MTV and TLG after the application of the deep learning tool were feasible in all patients. A significant positive correlation (p < 0.05) was observed between the results of the visual analysis of the PET/CT scans for the three patient groups and the MTV and TLG values after the employment of all six [18F]FDG uptake thresholds. In addition, there were significant differences between the three patient groups with regard to their MTV and TLG values for all applied thresholds of pathological tracer uptake. Furthermore, we could demonstrate a significant, moderate, positive correlation of BM plasma cell infiltration and plasma levels of β2-microglobulin with the automated quantitative PET/CT parameters MTV and TLG after utilization of Approaches 1, 2, 4, and 5. CONCLUSIONS: The automated, volumetric, whole-body PET/CT assessment of the BM metabolic activity in MM is feasible with the herein applied method and correlates with clinically relevant parameters in the disease. This methodology offers a potentially reliable tool in the direction of optimization and standardization of PET/CT interpretation in MM. Based on the present promising findings, the deep learning-based approach will be further evaluated in future prospective studies with larger patient cohorts.
引用
- Sachpekidis C, Enqvist O, Ulén J, et al. Application of an artificial intelligence-based tool in [18F]FDG PET/CT for the assessment of bone marrow involvement in multiple myeloma. Eur J Nucl Med Mol Imaging. 2023. PMID: 37493665. doi:10.1007/s00259-023-06339-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。